Becton Dickinson & Co (BDX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$641.00M
As of 2025-09-30
$708.00M
As of 2026-06-30
-13.9%
3-year compound annual growth
-25.7%
5-year compound annual growth
-7.7%
10-year compound annual growth
$14.18B2007-09-30: $511.48M2008-09-30: $830.48M2009-09-30: $1.39B2010-09-30: $1.22B2011-09-30: $1.18B2012-09-30: $1.67B2013-09-30: $1.89B2014-09-30: $1.86B2015-09-30: $1.42B2016-09-30: $1.54B2017-09-30: $14.18B2018-09-30: $1.14B2019-09-30: $536.00M2020-09-30: $2.83B2021-09-30: $2.28B2022-09-30: $1.01B2023-09-30: $1.42B2024-09-30: $1.72B2025-09-30: $641.00M$641.00M
2007-09-30 Cash & Equivalents (USD) 2025-09-30
Period endedCash & EquivalentsChange YoYSource filing
2025-09-30$641.00M-62.7%2025-11-25, Balance as of period end
2024-09-30$1.72B+21.3%2025-11-25, Balance as of period end
2023-09-30$1.42B+40.8%2024-11-27, Balance as of period end
2022-09-30$1.01B-55.9%2023-11-21, Balance as of period end
2021-09-30$2.28B-19.2%2022-11-22, Balance as of period end
2020-09-30$2.83B+427.1%2021-11-24, Balance as of period end
2019-09-30$536.00M-53.0%2020-11-25, Balance as of period end
2018-09-30$1.14B-92.0%2019-11-27, Balance as of period end
2017-09-30$14.18B+820.1%2018-11-21, Balance as of period end
2016-09-30$1.54B+8.2%2018-11-21, Balance as of period end
2015-09-30$1.42B-23.5%2017-11-22, Balance as of period end
2014-09-30$1.86B-1.5%2016-11-23, Balance as of period end
2013-09-30$1.89B+13.1%2015-11-25, Balance as of period end
2012-09-30$1.67B+42.2%2014-11-26, Balance as of period end
2011-09-30$1.18B-3.4%2013-11-27, Balance as of period end
2010-09-30$1.22B-12.8%2012-11-21, Balance as of period end
2009-09-30$1.39B+67.9%2011-11-23, Balance as of period end
2008-09-30$830.48M+62.4%2010-11-24, Balance as of period end
2007-09-30$511.48Mn/a2010-01-21, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Becton Dickinson & Co (BDX)2025-09-30$641.00M-62.7%
Boston Scientific Corp (BSX)2025-12-31$1.97B+374.6%
Stryker Corp (SYK)2025-12-31$4.01B+9.8%
Medline Inc. (MDLN)2025-12-31$1.94B+874.4%
Baxter International Inc (BAX)2025-12-31$1.97B+11.5%
Solventum Corp (SOLV)2025-12-31$878.00M+15.2%
ResMed Inc (RMD)2026-06-30$1.47B+21.5%
Dexcom Inc (DXCM)2025-12-31$917.70M+51.4%
MiniMed Group, Inc. (MMED)2026-04-24$298.00Mn/m

Compare BDX, BSX, SYK, MDLN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗